Effect of carnitine on migraine prophylaxis
Phase 3
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20190702044073N1
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
The number of headache attacks is 4 or more in a month
15 to 60 years old
No brain degenerative disease.
No Pregnancy and lactation
they are not alcoholic or drug user
They did not have psychiatric disease or chronic liver or kidney disorders
No chronic consumption of pain killer
They did not use psychedelic drug
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache severity. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method Duration of headache attack. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: hour.;Frequency of headache repetition. Timepoint: At the beginning of the study and one month after taking L-Carnitine. Method of measurement: Frequency of headache repetition in one month.;Age. Timepoint: At the beginning of the study. Method of measurement: year old.;Sex. Timepoint: At the beginning of the study. Method of measurement: male , female.